<i>PRF1</i> mutation alters immune system activation, inflammation, and risk of autoimmunity

Carlo Sidore(Institute of Genetic and Biomedical Research), Valeria Orrù(Institute of Genetic and Biomedical Research), Eleonora Cocco(University of Cagliari), Maristella Steri(Institute of Genetic and Biomedical Research), Jamie Inshaw(Centre for Human Genetics), Maristella Pitzalis(Institute of Genetic and Biomedical Research), Antonella Mulas(Institute of Genetic and Biomedical Research), Stuart J. McGurnaghan(University of Edinburgh), Jessica Frau(University of Cagliari), Eleonora Porcu(SIB Swiss Institute of Bioinformatics), Fabio Busonero(Institute of Genetic and Biomedical Research), Mariano Dei(Institute of Genetic and Biomedical Research), Sandra Lai(Institute of Genetic and Biomedical Research), Gabriella Sole(Institute of Genetic and Biomedical Research), Francesca Virdis(Institute of Genetic and Biomedical Research), Valentina Serra(Institute of Genetic and Biomedical Research), Fausto Poddie(University of Sassari), Alessandro Delitala(University of Sassari), Michele Marongiu(Institute of Genetic and Biomedical Research), Francesca Deidda(Institute of Genetic and Biomedical Research), Mauro Pala(Institute of Genetic and Biomedical Research), Matteo Floris(University of Sassari), Marco Masala(Institute of Genetic and Biomedical Research), Suna Önengüt-Gümüşcü(University of Virginia), Catherine C. Robertson(University of Virginia), Lidia Leoni(Center for Advanced Studies Research and Development in Sardinia), Annapaola Frongia(Azienda Ospedaliera G. Brotzu), Maria Rossella Ricciardi(Azienda Ospedaliera G. Brotzu), Margherita Chessa(Azienda Ospedaliera G. Brotzu), Nazario Olla(Institute of Genetic and Biomedical Research), Mario Lovicu(Institute of Genetic and Biomedical Research), Annalisa Loizedda(Institute of Genetic and Biomedical Research), Andrea Maschio(Institute of Genetic and Biomedical Research), Luisa Mereu(Fondazione Centro Marino Internazionale), Paola Ferrigno(Azienda Ospedaliera G. Brotzu), Nicolò Curreli(Institute of Genetic and Biomedical Research), Lenuta Balaci(Institute of Genetic and Biomedical Research), Francesco Loi(Institute of Genetic and Biomedical Research), Liana AP Ferreli(Institute of Genetic and Biomedical Research), Maria Grazia Pilia(Institute of Genetic and Biomedical Research), Antonello Pani(Institute of Genetic and Biomedical Research), Maria Giovanna Marrosu(University of Cagliari), Gonçalo R. Abecasis(University of Michigan), Stephen S. Rich(University of Virginia), Helen M. Colhoun(University of Edinburgh), John A. Todd(Centre for Human Genetics), David Schlessinger(National Institutes of Health), Edoardo Fiorillo(Institute of Genetic and Biomedical Research), Francesco Cucca(University of Sassari), Magdalena Żołędziewska(Institute of Genetic and Biomedical Research)
Multiple Sclerosis Journal
October 14, 2020
Cited by 32Open Access
Full Text

Abstract

Background: Defective alleles within the PRF1 gene, encoding the pore-forming protein perforin, in combination with environmental factors, cause familial type 2 hemophagocytic lymphohistiocytosis (FHL2), a rare, severe autosomal recessive childhood disorder characterized by massive release of cytokines—cytokine storm. Objective: The aim of this study was to determine the function of hypomorph PRF1:p.A91V g.72360387 G &gt; A on multiple sclerosis (MS) and type 1 diabetes (T1D). Methods: We cross-compare the association data for PRF1:p.A91V mutation derived from GWAS on adult MS and pediatric T1D in Sardinians. The novel association with T1D was replicated in metanalysis in 12,584 cases and 17,692 controls from Sardinia, the United Kingdom, and Scotland. To dissect this mutation function, we searched through the coincident association immunophenotypes in additional set of general population Sardinians. Results: We report that PRF1:p.A91V, is associated with increase of lymphocyte levels, especially within the cytotoxic memory T-cells, at general population level with reduced interleukin 7 receptor expression on these cells. The minor allele increased risk of MS, in 2903 cases and 2880 controls from Sardinia p = 2.06 × 10 −4 , odds ratio OR = 1.29, replicating a previous finding, whereas it protects from T1D p = 1.04 × 10 −5 , OR = 0.82. Conclusion: Our results indicate opposing contributions of the cytotoxic T-cell compartment to MS and T1D pathogenesis.


Related Papers

No related papers found

Powered by citation graph analysis